Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 0 | 0 | 0 | 318 | 645 |
| Cost of Goods | N/A | N/A | N/A | 355 | 337 |
| Gross Profit | N/A | N/A | N/A | -37 | 308 |
| Operating Expenses | 573 | 1,528 | 1,040 | -5,609 | 2,607 |
| Operating Income | -573 | -1,528 | -1,040 | 5,927 | -1,962 |
| Interest Expense | 47 | 46 | 46 | 63 | 105 |
| Other Income | 495 | 260 | 71 | 177 | 504 |
| Pre-tax Income | -125 | -1,314 | -1,014 | 6,041 | -1,564 |
| Income Tax | N/A | N/A | N/A | 2,653 | N/A |
| Net Income Continuous | -125 | -1,314 | -1,014 | 3,388 | -1,564 |
| Net Income | $-125 | $-1,314 | $-1,014 | $3,388 | $-1,564 |
| EPS Basic Total Ops | -0.05 | -0.50 | -0.38 | 1.61 | -0.71 |
| EPS Basic Continuous Ops | -0.05 | -0.50 | -0.38 | 1.63 | -0.71 |
| EPS Diluted Total Ops | -0.05 | -0.50 | -0.38 | 1.61 | -0.71 |
| EPS Diluted Continuous Ops | -0.05 | -0.50 | -0.38 | 1.63 | -0.71 |
| EBITDA(a) | $-273 | $-1,246 | $-742 | $6,156 | $-1,562 |